HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dosing of a phase I study of KW-0761, an anti-CCR4 antibody, for adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.

AuthorsRitsuro Suzuki
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 28 Issue 23 Pg. e404-5; author reply e406 (Aug 10 2010) ISSN: 1527-7755 [Electronic] United States
PMID20566994 (Publication Type: Letter, Comment)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • CCR4 protein, human
  • Receptors, CCR4
  • mogamulizumab
Topics
  • Antibodies, Monoclonal (administration & dosage)
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials, Phase I as Topic
  • Dose-Response Relationship, Drug
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell (drug therapy)
  • Lymphoma, T-Cell, Peripheral (drug therapy)
  • Maximum Tolerated Dose
  • Receptors, CCR4 (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: